Building an MBMA Framework to Support Developing New Neuropathic Pain Drugs

April 24, 2019 – Model-Based Meta-Analysis (MBMA) is a growing methodology that leverages literature based and often external data to provide a quantitative framework to enable strategic drug development decisions. MBMA comparator models often include valuable pieces of information such as time, covariates, clinical trial efficacy and safety information.

Read More
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog